New York Life Investment Management’s MasTec MTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.65M Buy
8,238
+2,483
+43% +$672K 0.02% 480
2025
Q4
$1.25M Sell
5,755
-657
-10% -$138K 0.01% 574
2025
Q3
$1.36M Sell
6,412
-233
-4% -$42.7K 0.01% 607
2025
Q2
$1.13M Sell
6,645
-154
-2% -$22.2K 0.01% 623
2025
Q1
$794K Buy
6,799
+78
+1% +$10.5K 0.01% 695
2024
Q4
$915K Sell
6,721
-554
-8% -$74.3K 0.01% 673
2024
Q3
$896K Sell
7,275
-417
-5% -$45.5K 0.01% 719
2024
Q2
$823K Buy
7,692
+1,380
+22% +$139K 0.01% 722
2024
Q1
$589K Sell
6,312
-336
-5% -$25.6K 0.01% 769
2023
Q4
$503K Sell
6,648
-76
-1% -$4.75K 0.01% 831
2023
Q3
$484K Buy
6,724
+3,674
+120% +$366K 0.01% 780
2023
Q2
$360K Buy
+3,050
New +$299K ﹤0.01% 1141

Other funds holding MTZ

New York Life Investment Management's MTZ Position: Q1 2026 in Review

New York Life Investment Management increased its MasTec (MTZ) stake by 43% in Q1 2026, buying an estimated $672K and bringing the position to 8,238 shares worth $2.65M. The position accounts for 0.02% of the portfolio, ranked #480.

New York Life Investment Management first reported a position in MTZ in Q2 2023 and has held it in 12 quarters since. 807 funds tracked by Wall St. Rank hold MTZ as of Q1 2026.

  • New York Life Investment Management held 8,238 shares of MasTec worth $2.65M as of Q1 2026.
  • New York Life Investment Management bought 2,483 MasTec shares in Q1 2026, an estimated $672K.
  • MasTec made up 0.02% of New York Life Investment Management's portfolio in Q1 2026, its #480 holding.
  • New York Life Investment Management first reported a position in MasTec in Q2 2023 and has held it in 12 quarters since.
  • 807 funds tracked by Wall St. Rank held MasTec as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.